Prolonged remission with ibrutinib maintenance therapy following radiation in a patient with relapsed primary CNS lymphoma

Prolonged remission with ibrutinib maintenance therapy following radiation in a patient with relapsed primary CNS lymphoma

Background: Treatment for refractory or relapsed primary CNS lymphoma (r/r PCNSL) is challenging. Salvage whole-brain radiation therapy (WBRT) is an option but has a short duration of disease control, so additional treatment modalities are warranted. Case: A 75-year-old female with r/r PCNSL who had...

Full description

Saved in:
Bibliographic Details
Main Authors: Steven Du, Dan Beverly Fu, Daniela A Bota, Xiao-Tang Kong
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:CNS Oncology
Subjects:
Bruton's tyrosine kinase inhibitor
diffuse large B-cell lymphoma
ibrutinib
primary CNS lymphoma
relapsed or refractory primary CNS lymphoma
whole-brain radiation therapy
Online Access:https://www.tandfonline.com/doi/10.1080/20450907.2024.2345579
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/20450907.2024.2345579

Similar Items